Novartis AG is 13.4x more valuable than Roivant Sciences Ltd. by market capitalization ($282.64 B vs $21.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ROIV | NVS |
|---|---|---|
| Market cap | $21.12 B | $282.64 B |
| US-listed rank | #603 | #47 |
| Revenue (latest FY) | $8.26M | - |
| Net income (latest FY) | -$299.77M | - |
| Net margin | -3629.2% | - |
| SEC filings | 868 | 947 |
Novartis AG is 13.4x more valuable than Roivant Sciences Ltd. by market capitalization ($282.64 B vs $21.12 B).
Full pages: Roivant Sciences Ltd. and Novartis AG, or browse the full rankings.